During the past 12 months, PharmaCyte Biotech's average Book Value per Share Growth Rate was -13.10% per year.
During the past 3 years, the average Book Value per Share Growth Rate was -2.40% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -12.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of PharmaCyte Biotech was 28.40% per year. The lowest was -405.80% per year. And the median was -19.45% per year.
Competitive Comparison of PharmaCyte Biotech's 3-Year Book Growth Rate
For the Biotechnology subindustry, PharmaCyte Biotech's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaCyte Biotech's 3-Year Book Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PharmaCyte Biotech's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where PharmaCyte Biotech's 3-Year Book Growth Rate falls into.
PharmaCyte Biotech 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
PharmaCyte Biotech (NAS:PMCB) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
PharmaCyte Biotech 3-Year Book Growth Rate Related Terms
Thank you for viewing the detailed overview of PharmaCyte Biotech's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
PharmaCyte Biotech (PharmaCyte Biotech) Business Description
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PMCB has been successfully added to your